Wacker Biotech US
Wacker Biotech US
Revolutionizing Plasmid DNA: Wacker and Gearbox Unite!
Wacker and Gearbox Biosciences unite to revolutionize plasmid DNA manufacturing! 🌟 Together, they prioritize sustainability, innovation, and quality. 🧬🏬
Powerful Partnership Boosts Gene Therapy Advancements!
🌟 Wacker Biotech and Expression Manufacturing unite to enhance lentiviral therapies! 🔬 Together, they simplify viral vector development and production. 💡🚀
Game-Changing mRNA Partnership Boosts Drug Development!
🌟 Wacker Biotech and RNAV8 Bio join forces to enhance mRNA therapeutics, promising better outcomes and faster drug development! 🚀💡📈
Powering Up for Future Pandemics: 80M Vaccines!
🌍 Wacker Biotech is ready to combat future pandemics with a new mRNA facility in Halle, Germany, producing 80 million doses! 💉🛠️
Game-Changer: New Vaccine to Protect Newborns!
🌟 Exciting collaboration! MinervaX and Wacker are developing a Group B Streptococcus vaccine to protect newborns from infections. 💉🔬🌍
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
Wacker Biotech US Expands San Diego Facility Boosting Production Capacity and Advancing Medical Therapies
📣 Wacker Biotech US is expanding its San Diego facility, offering larger fermentation lines for mRNA and protein production. 💪 This expansion will create more capabilities for advanced therapy medicinal products. 🧪 New labs will support bioprocess development for pDNA, mRNA, and recombinant proteins. 🔬 This complements their nucleic acid expertise and supports research and preclinical development.
